The stock market has taken a pounding thus far in Q122 and small cap biopharma stocks seem to have been hit the hardest. These small cap companies can...
Heads up members unscheduled FED meeting Monday February 14th at 11:30AM EST with one item on agenda INTEREST RATES!
We Can not wait to see what the FED does now, we may finally have some more insight into policy and hopefully the first rate increase of the year to s...
Both of our reports from last week moving and still in play!
Are Big Market Swings an Opportunity for Gains? Good day everyone, Our most recent report on IMMX resulted in a potential 18.5% benefit for our member...
We Are Kicking Off Our Rebound And Hot Sector Reports Tomorrow Near Market Open
Recent Earnings Reports Are Looking Good We Are Kicking Off Our Rebound And Hot Sector Reports Tomorrow Near Market Open Good day everyone, January 20...
The Broader Market’s are in Correction Territory. We have a new Biotech company report that will be available tomorrow 01-24-22 at market open.
The Broader Market’s are in Correction Territory We have a new Biotech company report that will be available tomorrow 01-24-22 at market open. ...
Flora Growth (FLGC) May be the Best NASDAQ Value in Cannabis Companies Right Now With Expanding Operations. This is a Must See Report.
Trading at 84% off analyst’s consensus target of $10.75/share Trading at 92% off its August high of $21.45/share Good day everyone and welcome to all ...
A New to the NASDAQ Company That Offers Great Potential with a Robust Biopharma Pipeline, Tiny Market Cap and an Approved Product Ready for Distribution
Good day everyone, We want to report on a company in the biopharma sector that is new to the NASDAQ. This clinical stage company has solid financial m...
Meet SciSparc Ltd. (NASDAQ: SPRC) the Cannabis biotech disruptor with potential pipeline revenues of about $490M and they already have an approved drug in Canada! Float approx. 2.3M shares.
We Love This Stock! SciSparc Ltd. (NASDAQ: SPRC) already has a fully approved commercial product CannAmide, approved by Health Canada. CannAmide™ is r...
Biotricity (NASDAQ: BTCY) Well Positioned With Impressive Revenue Growth and Near-Term Catalysts
Biotricity (BTCY) Could Be a Case Study for a Well Managed Businesses with Their Rapid Growth, Controlled Costs and a New Non-Dilutive Financing Deal ...
I’m Feeling Optimistic About 2022 and Growth in the Markets, Are You? New NASDAQ Report Will be Available Tuesday Dec. 28th Near Market Open.
NASDAQ report coming tomorrow near market open that I’m feeling really good about! Good day everyone and welcome to all of our new trading group membe...